Woodline Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Woodline Partners’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,736	Closed	-$2.28M	–	294
2020 Q3	$2.28M	Sell	16,736 -97,303	-85%	-$10.3M	0.07%	160
2020 Q2	$11M	Buy	114,039 +49,731	+77%	+$4.15M	0.44%	68
2020 Q1	$3.02M	Sell	64,308 -19,515	-23%	-$1.25M	0.22%	108
2019 Q4	$6.11M	Buy	+83,823	New	+$5.08M	0.25%	85

Woodline Partners's MYOK Position: Q4 2020 in Review

Woodline Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 16,736 shares — an estimated $2.28M sold.

Woodline Partners first reported a position in MYOK in Q4 2019 and held it in 4 quarters. The position peaked at $11M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Woodline Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Woodline Partners sold 16,736 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.28M.
Woodline Partners first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Woodline Partners's MyoKardia, Inc. Common Stock position peaked at $11M in Q2 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.